Reo Therapeutics Secures £170k in Early-Stage Funding
Reo Therapeutics Limited, a London-based biotechnology firm, has successfully raised £170k in a recent funding round. The capital infusion, with an allotment date of 25 March 2026 and filing on 23 Apr...